Mercado europeo de pruebas en el punto de atención (POCT): tendencias de la industria y pronóstico hasta 2029

Análisis y perspectivas del mercado de pruebas en el punto de atención (POCT) en Europa

Las pruebas en el punto de atención (POCT) se caracterizan por ser pruebas que se pueden realizar cerca del paciente, donde se puede tomar una decisión médica de inmediato, incluidos los resultados y el seguimiento. La mayor prevalencia de enfermedades infecciosas y crónicas, la mejora en la tasa de búsqueda de diagnósticos y la creciente preferencia por las pruebas domiciliarias son algunos de los principales impulsores del crecimiento del mercado.

Sin embargo, la falta de alineación con los resultados de las pruebas obtenidas de los laboratorios, el alto costo y la falta de personal capacitado son algunos de los desafíos que obstaculizan el crecimiento del mercado.

Se espera que el mercado europeo de pruebas en el punto de atención (POCT) gane crecimiento de mercado en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 8,8% en el período de pronóstico de 2022 a 2029 y se espera que alcance los USD 13.085,33 millones para 2029.

Definición de mercado

Point of Care Testing (POCT) is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within a few minutes as compared to hours. Currently, there are various products available that provide rapid and accurate results and help in patient’s better outcomes which is expected to provide various other opportunities for the market growth. However, lack of alignment in lab results and high cost of POCT products are expected to restrain the market growth in the forecast period.

Europe point of care testing (POCT) market report provides details of market share, new developments, product pipeline analysis and impact of domestic and localized market players that analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Point of Care Testing (POCT) Market Dynamics

Drivers

• Increasing prevalence of infectious and chronic diseases

The prevalence of infectious and chronic diseases such as cancer, diabetes and cardiovascular disorder is rapidly increasing across Europe. According to the World Health Organization (WHO), the contribution of chronic diseases was about 60% which accounted for the number of deaths. In Europe, the major reason behind the increasing number of chronic diseases is the increasing number of geriatric population. These increasing rates of the diseases are directly proportional to the market growth of POCT devices as they are used in the diagnosis of almost all diseases. We also know that as health degeneration begins with aging, the rate of chronic diseases and factors associated with them also increase with time. However, with increase in disease rate, the healthcare system and status of health is also improving due to awareness and adoption of POCT devices that help in the diagnosis of multiple chronic diseases thereby, driving the market growth.

For instance,

• In October 2017, according to a report published in Springer, 85% of deaths in the European Union (EU) were due to chronic diseases including cancer, cardiovascular disease, chronic respiratory disease, diabetes and mental illness

The growing incidences of chronic diseases in Europe with conditions like cancer, asthma and heart disease among others have improved the usage and awareness about early diagnosis of diseases. This awareness made people buy more healthcare premiums including whole body check-ups regularly that includes almost all the tests. At the same time, the population of chronic diseases is rapidly increasing.

 Thus, a major surge in the prevalence of chronic diseases will be acting as a major driver for the market growth as POCT devices can effectively manage the disorder and provide better comfort and treatment for monitoring whenever needed.

• Improved diagnosis-seeking rate

Improved healthcare professionals and regular training sessions for the professionals conducting tests have contributed to the improved diagnosis rates in the region, which includes an increase in the successful diagnosis of chronic diseases like cancer, cardiovascular disease, type 2 diabetes and others. The rate of diagnosis also increases as the burden of disease increases. Healthcare and IT professionals have the power to decrease the likelihood of error and are making attempts to increase the rate of seeking POCT. Along with that, they also help in determining and detecting the risk associated with it. Perhaps, to improve the rate of diagnosis the IT professionals evaluate the user experience also.

To support the POCT process, a methodology was introduced that includes coverage of management, time spent by professionals for diagnosis and evaluation activities that would help in improving the accuracy rate of the information and help in making better decisions in terms of diagnosis. Thus, the efforts by the healthcare and IT professionals, improved training of healthcare professionals, change in the patient care delivery system and improved diagnosis-seeking rate in the region are leading to the market growth.

• Rising preference for homecare testing

Increased demand for homecare testing results in reduced error and safety with ensured quality clinical information that will be available at appropriate time and location and also helps to understand the elder case of a medical emergency. The market has been growing due to rising geriatric population thereby, increasing the demand for homecare testing. With the help of cutting-edge modern technologies, home health care costs have been dramatically reduced and people are being helped effectively. Thus, increased preferences for home healthcare services will boost the demand for POCT devices driving the market growth.

Opportunity

• Strategic initiatives by the market players

The increase in the prevalence of chronic and infectious diseases in Europe requires new and advanced POCT kits and solutions with improved efficacy rate and reduced cycle time due to rise in the geriatric population and also to improve the healthcare management and diagnostics for quality performance. Major market leaders are engaged in full filling the demands of healthcare professionals and spending their time in research to produce better products, kits and reagents.

These strategic initiatives by the companies including acquisition and focused segment product launches are helping them to expand and enhance the product portfolio of the company which will ultimately lead to more revenue generation. Hence, these strategic initiatives by the market players are acting as an opportunity that is helping them to drive market growth.

Restraint/Challenge

• Lack of alignment with test results obtained from laboratories

The POCT results when compared with laboratory testing standards can differ and be performed by clinical personnel who are not trained in clinical laboratory sciences. The standardization and other essential criteria cannot be completed by POCT and this is acting as a major challenge for the market growth.

Given the advantages of POCT research, some downsides are not necessarily considered the safest choice. Owing to the sensitivity and precision associated with laboratory analyzers, clinical laboratory personnel are well aware of the analytical methodologies and are more reliable. In comparison, the test carried out by healthcare personnel rather than laboratory qualified persons resulted in mistakes arising from lack of awareness on the significance of quality management and quality assurance procedures. Thus, more precise and accurate results can be expected from laboratory testing as POCT faces challenges to meet all specific standards of testing due to lack of knowledge.

Recent Developments

• In May 2022, Abbott updated i-STAT software for hospitals and outpatient facilities to provide solution in real-time. The software consists of high efficacy rate, is cost-effective and provides good quality patient care decision-making
• In May 2022, EKF Diagnostics announced the launch of its new EKF Link digital connectivity solution for the secure management of POC analyzers and associated data on one centralized platform

Europe Point of Care Testing (POCT) Market Scope

Europe point of care testing (POCT) market is segmented into product, application, end user, mode of testing and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Instruments
• Consumables & Reagents
• Others

Based on product, the market is segmented into instruments, consumables & reagents and others.

Application

• Blood Glucose
• Cardiac Monitoring
• Coagulation
• Whole Blood Analysis
• Vital Sign Monitoring
• Infectious Disease Testing
• Urine Analysis
• Cholesterol Testing
• Others

Based on application, the market is segmented into blood glucose, cardiac monitoring, coagulation, whole blood analysis, vital sign monitoring, infectious disease testing, urine analysis, cholesterol testing and others.

End User

• Laboratories
• Hospitals
• Clinics
• Ambulatory Centers
• Home Care
• Assisted Living Facilities
• Pharmacies/Drug Stores
• Others

Según el usuario final, el mercado está segmentado en laboratorios, hospitales, clínicas, centros ambulatorios, atención domiciliaria, centros de vida asistida, farmacias/droguerías y otros.

Modo de prueba

• Pruebas basadas en prescripción médica
• Pruebas de venta libre

Según el modo de prueba, el mercado está segmentado en pruebas con prescripción médica y pruebas de venta libre.

 Canal de distribución

• Ventas directas
• Distribuidor externo
• Venta en línea

Según el canal de distribución, el mercado está segmentado en venta directa, distribuidor externo y venta en línea.

Análisis y perspectivas regionales del mercado de pruebas en el punto de atención (POCT) en Europa      

Se analiza el mercado europeo de pruebas en el punto de atención (POCT) y se proporcionan información y tendencias sobre el tamaño del mercado por producto, aplicación, usuario final, modo de prueba y canal de distribución.

Los países que abarca este mercado son Alemania, Francia, Reino Unido, Italia, España, Países Bajos, Rusia, Suiza, Turquía, Bélgica y el resto de Europa. Alemania domina el mercado europeo de pruebas en el punto de atención (POCT) en términos de participación de mercado e ingresos de mercado y seguirá aumentando su dominio durante el período de pronóstico. Esto se debe a la mayor conciencia sobre los dispositivos POCT en la región europea.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en las regulaciones del mercado que afectan las tendencias actuales y futuras del mercado. Los puntos de datos, como las ventas nuevas y de reemplazo, la demografía del país, la epidemiología de las enfermedades y los aranceles de importación y exportación, son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la alta competencia de las marcas locales y nacionales y el impacto de los canales de venta se consideran al proporcionar un análisis de pronóstico de los datos del país.

Análisis del panorama competitivo y de la cuota de mercado de las pruebas en el punto de atención (POCT) en Europa

El panorama competitivo del mercado de pruebas en el punto de atención brinda detalles de los competidores. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos y el dominio de las aplicaciones. Los puntos de datos proporcionados anteriormente solo están relacionados con el enfoque de las empresas en el mercado de pruebas en el punto de atención.

Algunos de los principales actores que operan en este mercado son Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, Inc., QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics y Sysmex Europe SE, entre otros.

SKU-33910